Axillary Hyperhidrosis Treatment Market
Axillary Hyperhidrosis Treatment Market: Global Industry Analysis 2017-2022 and Opportunity Assessment 2023-2033
A recent market study published by FMI on Axillary Hyperhidrosis Treatment offers a global industry analysis for 2017-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.
Market Segmentation
By Treatment:
- Drug Therapy
- Antiperspirants (Both OTC & Rx)
- Antihypertensive Drugs
- Anticholinergic Agents
- Alpha-Adrenergic Agonists
- Botulinum Toxins
- Medicated Wipes
- Microwave Therapy
- Hospitals
- General Physician’s Clinics
- Retail Pharmacy Chains
- Drug Stores
- Online Sales
- Manufacturer websites
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Executive Summary
The executive summary of the Axillary Hyperhidrosis Treatment Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Vehicle Radar Test System.
Chapter 01 - Market Overview
Readers can find the detailed segmentation and definition of the Axillary Hyperhidrosis Treatment Market in this chapter, which will help to understand basic information about Vehicle Radar Test System. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Axillary Hyperhidrosis Treatment Market report.
Chapter 02 - Market Background
This chapter includes detailed analysis of the By Treatment processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.
Chapter 03 - Global Axillary Hyperhidrosis Treatment Market Demand Analysis 2017-2022 and Forecast, 2023-2033
The chapter include historical market value (US$ 1.6 Billion) analysis (2017-2022) and current and future market value (US$ 1.8 Billion) and volume (6.7%) projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.
Chapter 04 - Global Axillary Hyperhidrosis Treatment Market - Pricing Analysis
Based on By Treatment, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.
Chapter 05 - Global Axillary Hyperhidrosis Treatment Market Analysis 2017-2022 and Forecast 2023-2033, By Treatment
Based on By Treatment, Axillary Hyperhidrosis Treatment Market is segmented into Drug Therapy (Antiperspirants, Antihypertensive Drugs, Anticholinergic Agents, Alpha-Adrenergic Agonists), Botulinum Toxins, Medicated Wipes, Microwave Therapy. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Treatment.
Chapter 06 - Global Axillary Hyperhidrosis Treatment Market Analysis 2017-2022 and Forecast 2023-2033, By Distribution Channel
Based on By Distribution Channel, Axillary Hyperhidrosis Treatment Market is segmented into Hospitals, General Physician’s Clinics, Retail Pharmacy Chains, Drug Stores (Online Sales, Manufacturer websites). This section also offers market attractiveness analysis based on By Distribution Channel. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Distribution Channel.
Chapter 07 - Axillary Hyperhidrosis Treatment Market Analysis 2017-2022 and Forecast 2023-2033, By Region
Based on By Region, Axillary Hyperhidrosis Treatment Market is segmented into North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA). This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.
Chapter 08 - North America Axillary Hyperhidrosis Treatment Market Analysis 2017-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of the Vehicle Radar Test System in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.
Chapter 09 - Latin America Axillary Hyperhidrosis Treatment Market Analysis 2017-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Axillary Hyperhidrosis Treatment Market in the Latin America region.
Chapter 10 - Europe Axillary Hyperhidrosis Treatment Market Analysis 2017-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Axillary Hyperhidrosis Treatment Market in the regional market.
Chapter 11 - East Asia Axillary Hyperhidrosis Treatment Market Analysis 2017-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Axillary Hyperhidrosis Treatment Market in the regional market.
Chapter 12 - South Asia Axillary Hyperhidrosis Treatment Market Analysis 2017-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Axillary Hyperhidrosis Treatment Market in the regional market.
Chapter 13 - Middle East and Africa Axillary Hyperhidrosis Treatment Market Analysis 2017-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Axillary Hyperhidrosis Treatment Market in the regional market.
Chapter 14 - Key Countries Axillary Hyperhidrosis Treatment Market Analysis 2017-2022 and Forecast 2023-2033
This chapter offers insights into how the Axillary Hyperhidrosis Treatment Market is expected to grow in major countries globally.
Chapter 15 - Market Structure Analysis- Global Assessment
This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.
Chapter 16 - Competition Deep Dive (Tentative List)
This chapter includes company overview, By Treatment portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Allergan plc. (AbbVie), Journey Medical Corporation (Dermira, Inc.), Riemann A/S (Orkla), SweatBlock, Certain Dri, miraDry, Inc. (Sientra), STRATUS PHARMACEUTICALS INC, Duradry, Persn & Covey, GlaxoSmithKline Plc., Carpe, SweatStop® International, CORAD Healthcare, ZeroSweat.
Chapter 17 - Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Vehicle Radar Test System report.
Chapter 18 - Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Axillary Hyperhidrosis Treatment Market.
- 1. Executive Summary | Axillary Hyperhidrosis Treatment Market
- 1.1. Global Market Outlook
- 1.2. Demand Side Trends
- 1.3. Supply-Side Side Trends
- 1.4. Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 2.3. Inclusions and Exclusions
- 3. Key Market Trends
- 3.1. Key Trends Impacting the Market
- 3.2. Innovation / Development Trends
- 4. Value Added Insights
- 4.1. Disease Epidemiology
- 4.2. Patent Analysis
- 4.3. Pipeline Assessment
- 4.4. Value Chain Analysis
- 4.5. Regulatory Scenario
- 4.6. PESTLE Analysis
- 4.7. Porter’s Analysis
- 5. Market Background
- 5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Spending Outlook
- 5.1.3. Global Dermatology Therapeutics Market Overview
- 5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Increasing Prevalence of Axillary Hyperhidrosis
- 5.2.2. Treatment Seeking Rate (%)
- 5.2.3. Adoption of Various Treatment Modalities
- 5.2.4. Greater Demand for Non-Invasive Procedures
- 5.2.5. Increasing Initiatives by Manufacturers to Educate the General Population
- 5.2.6. Products in Pipeline
- 5.2.7. Availability of Products
- 5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis
- 6. COVID-19 Crisis Analysis
- 6.1. COVID-19 and Impact Analysis
- 6.1.1. By Treatment
- 6.1.2. By Distribution Channel
- 6.1.3. By Country
- 6.2. 2022 Market Scenario
- 7. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
- 7.1. Historical Market Value (US$ Million) Analysis 2017 to 2022
- 7.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis
- 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Treatment
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size (US$ Million) Analysis By Treatment, 2017 to 2022
- 8.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Treatment, 2023 to 2033
- 8.3.1. Drug Therapy
- 8.3.1.1. Antiperspirants (Both OTC & Rx)
- 8.3.1.1.1. Antiperspirants Spray
- 8.3.1.1.2. Antiperspirants Roll-On
- 8.3.1.1.3. Antiperspirants Wipes
- 8.3.1.1.4. Antiperspirants Lotion & Gel
- 8.3.1.2. Antihypertensive Drugs
- 8.3.1.3. Anticholinergic Agents
- 8.3.1.4. Alpha-Adrenergic Agonists
- 8.3.2. Botulinum Toxins
- 8.3.3. Medicated Wipes
- 8.3.4. Microwave Therapy
- 8.4. Market Attractiveness Analysis By Treatment
- 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel
- 9.1. Introduction
- 9.2. Historical Market Size (US$ Million) Analysis By Distribution Channel, 2017 to 2022
- 9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033
- 9.3.1. Hospitals
- 9.3.2. General Physician’s Clinics
- 9.3.3. Retail Pharmacy Chains
- 9.3.4. Drug Stores
- 9.3.4.1. Online Sales
- 9.3.4.2. Manufacturer websites
- 9.4. Market Attractiveness Analysis By Distribution Channel
- 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
- 10.1. Introduction
- 10.2. Historical Market Value (US$ Million) Analysis By Region, 2017 to 2022
- 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Region, 2023 to 2033
- 10.3.1. North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. South Asia
- 10.3.5. East Asia
- 10.3.6. Oceania
- 10.3.7. Middle East & Africa
- 10.4. Market Attractiveness Analysis By Region
- 11. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
- 11.1. Introduction
- 11.2. Historical Market Value (US$ Million) Analysis, By Market Taxonomy 2017 to 2022
- 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
- 11.3.1. By Country
- 11.3.1.1. USA
- 11.3.1.2. Canada
- 11.3.2. By Treatment
- 11.3.3. By Distribution Channel
- 11.4. Market Attractiveness Analysis
- 11.4.1. By Country
- 11.4.2. By Treatment
- 11.4.3. By Distribution Channel
- 11.5. Market Trends
- 11.6. Key Market Participants - Intensity Mapping
- 11.7. Drivers and Restraints - Impact Analysis
- 11.8. Country Level Analysis & Forecast
- 11.8.1. USA Market
- 11.8.1.1. Introduction
- 11.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 11.8.1.2.1. By Treatment
- 11.8.1.2.2. By Distribution Channel
- 11.8.2. Canada Market
- 11.8.3. Introduction
- 11.8.4. Market Analysis and Forecast by Market Taxonomy
- 11.8.4.1.1. By Treatment
- 11.8.4.1.2. By Distribution Channel
- 12. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
- 12.1. Introduction
- 12.2. Historical Market Value (US$ Million) Analysis, By Market Taxonomy 2017 to 2022
- 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
- 12.3.1. By Country
- 12.3.1.1. Brazil
- 12.3.1.2. Mexico
- 12.3.1.3. Argentina
- 12.3.1.4. Rest of Latin America
- 12.3.2. By Treatment
- 12.3.3. By Distribution Channel
- 12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Treatment
- 12.4.3. By Distribution Channel
- 12.5. Market Trends
- 12.6. Key Market Participants - Intensity Mapping
- 12.7. Drivers and Restraints - Impact Analysis
- 12.8. Country Level Analysis & Forecast
- 12.8.1. Brazil Market
- 12.8.1.1. Introduction
- 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 12.8.1.2.1. By Treatment
- 12.8.1.2.2. By Distribution Channel
- 12.8.2. Mexico Market
- 12.8.2.1. Introduction
- 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 12.8.2.2.1. By Treatment
- 12.8.2.2.2. By Distribution Channel
- 12.8.3. Argentina Market
- 12.8.4. Introduction
- 12.8.5. Market Analysis and Forecast by Market Taxonomy
- 12.8.5.1.1. By Treatment
- 12.8.5.1.2. By Distribution Channel
- 13. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
- 13.1. Introduction
- 13.2. Historical Market Value (US$ Million) Analysis, By Market Taxonomy 2017 to 2022
- 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
- 13.3.1. By Country
- 13.3.1.1. Germany
- 13.3.1.2. Italy
- 13.3.1.3. France
- 13.3.1.4. United kingdom
- 13.3.1.5. Spain
- 13.3.1.6. BENELUX
- 13.3.1.7. Russia
- 13.3.1.8. Nordic Countries
- 13.3.1.9. Rest of Europe
- 13.3.2. By Treatment
- 13.3.3. By Distribution Channel
- 13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Treatment
- 13.4.3. By Distribution Channel
- 13.5. Market Trends
- 13.6. Key Market Participants - Intensity Mapping
- 13.7. Drivers and Restraints - Impact Analysis
- 13.8. Country Level Analysis & Forecast
- 13.8.1. Germany Market
- 13.8.1.1. Introduction
- 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.1.2.1. By Treatment
- 13.8.1.2.2. By Distribution Channel
- 13.8.2. Italy Market
- 13.8.2.1. Introduction
- 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.2.2.1. By Treatment
- 13.8.2.2.2. By Distribution Channel
- 13.8.3. France Market
- 13.8.3.1. Introduction
- 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.3.2.1. By Treatment
- 13.8.3.2.2. By Distribution Channel
- 13.8.4. United kingdom Market
- 13.8.4.1. Introduction
- 13.8.4.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.4.2.1. By Treatment
- 13.8.4.2.2. By Distribution Channel
- 13.8.5. Spain Market
- 13.8.5.1. Introduction
- 13.8.5.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.5.2.1. By Treatment
- 13.8.5.2.2. By Distribution Channel
- 13.8.6. BENELUX Market
- 13.8.6.1. Introduction
- 13.8.6.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.6.2.1. By Treatment
- 13.8.6.2.2. By Distribution Channel
- 13.8.7. Russia Market
- 13.8.7.1. Introduction
- 13.8.7.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.7.2.1. By Treatment
- 13.8.7.2.2. By Distribution Channel
- 13.8.8. Nordic Countries Market
- 13.8.8.1. Introduction
- 13.8.8.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.8.2.1. By Treatment
- 13.8.8.2.2. By Distribution Channel
- 14. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
- 14.1. Introduction
- 14.2. Historical Market Value (US$ Million) Analysis, By Market Taxonomy 2017 to 2022
- 14.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
- 14.3.1. By Country
- 14.3.1.1. China
- 14.3.1.2. Japan
- 14.3.1.3. South Korea
- 14.3.2. By Treatment
- 14.3.3. By Distribution Channel
- 14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Treatment
- 14.4.3. By Distribution Channel
- 14.5. Market Trends
- 14.6. Key Market Participants - Intensity Mapping
- 14.7. Drivers and Restraints - Impact Analysis
- 14.8. Country Level Analysis & Forecast
- 14.8.1. China Market
- 14.8.1.1. Introduction
- 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.1.2.1. By Treatment
- 14.8.1.2.2. By Distribution Channel
- 14.8.2. Japan Market
- 14.8.2.1. Introduction
- 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.2.2.1. By Treatment
- 14.8.2.2.2. By Distribution Channel
- 14.8.3. South Korea Market
- 14.8.3.1. Introduction
- 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.3.2.1. By Treatment
- 14.8.3.2.2. By Distribution Channel
- 15. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
- 15.1. Introduction
- 15.2. Historical Market Value (US$ Million) Analysis, By Market Taxonomy 2017 to 2022
- 15.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
- 15.3.1. By Country
- 15.3.1.1. India
- 15.3.1.2. Indonesia
- 15.3.1.3. Malaysia
- 15.3.1.4. Thailand
- 15.3.1.5. Rest of South Asia
- 15.3.2. By Treatment
- 15.3.3. By Distribution Channel
- 15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Treatment
- 15.4.3. By Distribution Channel
- 15.5. Market Trends
- 15.6. Key Market Participants - Intensity Mapping
- 15.7. Drivers and Restraints - Impact Analysis
- 15.8. Country Level Analysis & Forecast
- 15.8.1. India Market
- 15.8.1.1. Introduction
- 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.1.2.1. By Treatment
- 15.8.1.2.2. By Distribution Channel
- 15.8.2. Indonesia Market
- 15.8.2.1. Introduction
- 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.2.2.1. By Treatment
- 15.8.2.2.2. By Distribution Channel
- 15.8.3. Malaysia Treatment Market
- 15.8.3.1. Introduction
- 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.3.2.1. By Treatment
- 15.8.3.2.2. By Distribution Channel
- 15.8.4. Thailand Market
- 15.8.4.1. Introduction
- 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.4.2.1. By Treatment
- 15.8.4.2.2. By Distribution Channel
- 16. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
- 16.1. Introduction
- 16.2. Historical Market Value (US$ Million) Analysis, By Market Taxonomy 2017 to 2022
- 16.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
- 16.3.1. By Country
- 16.3.1.1. Australia
- 16.3.1.2. New Zealand
- 16.3.2. By Treatment
- 16.3.3. By Distribution Channel
- 16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Treatment
- 16.4.3. By Distribution Channel
- 16.5. Market Trends
- 16.6. Key Market Participants - Intensity Mapping
- 16.7. Drivers and Restraints - Impact Analysis
- 16.8. Country Level Analysis & Forecast
- 16.8.1. Australia Treatment Market
- 16.8.1.1. Introduction
- 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.1.2.1. By Treatment
- 16.8.1.2.2. By Distribution Channel
- 16.8.2. New Zealand Treatment Market
- 16.8.2.1. Introduction
- 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.2.2.1. By Treatment
- 16.8.2.2.2. By Distribution Channel
- 17. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
- 17.1. Introduction
- 17.2. Historical Market Value (US$ Million) Analysis, By Market Taxonomy 2017 to 2022
- 17.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
- 17.3.1. By Country
- 17.3.1.1. GCC Countries
- 17.3.1.2. Türkiye
- 17.3.1.3. South Africa
- 17.3.1.4. North Africa
- 17.3.1.5. Rest of Middle East and Africa
- 17.3.2. By Treatment
- 17.3.3. By Distribution Channel
- 17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Treatment
- 17.4.3. By Distribution Channel
- 17.5. Market Trends
- 17.6. Key Market Participants - Intensity Mapping
- 17.7. Drivers and Restraints - Impact Analysis
- 17.8. Country Level Analysis & Forecast
- 17.8.1. GCC Countries Market
- 17.8.1.1. Introduction
- 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 17.8.1.2.1. By Treatment
- 17.8.1.2.2. By Distribution Channel
- 17.8.2. Türkiye Market
- 17.8.2.1. Introduction
- 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 17.8.2.2.1. By Treatment
- 17.8.2.2.2. By Distribution Channel
- 17.8.3. South Africa Market
- 17.8.3.1. Introduction
- 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 17.8.3.2.1. By Treatment
- 17.8.3.2.2. By Distribution Channel
- 17.8.4. North Africa Market
- 17.8.4.1. Introduction
- 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
- 17.8.4.2.1. By Treatment
- 17.8.4.2.2. By Distribution Channel
- 18. Market Structure Analysis
- 18.1. Market Analysis by Tier of Companies
- 18.2. Market Share Analysis (%) of Top Players
- 18.3. Market Presence Analysis
- 18.3.1. Regional Footprint of Players
- 18.3.2. Channel Foot Print by Players
- 19. Competition Analysis
- 19.1. Competition Dashboard
- 19.2. Competition Benchmarking
- 19.3. Promotional and Branding Strategies by Manufacturers
- 19.4. Competition Deep Dive
- 19.4.1. Allergan plc. (AbbVie)
- 19.4.1.1. Overview
- 19.4.1.2. Treatment Portfolio
- 19.4.1.3. Sales Footprint
- 19.4.1.4. Key Financials
- 19.4.1.5. SWOT Analysis
- 19.4.1.6. Strategy Overview
- 19.4.2. Journey Medical Corporation (Dermira, Inc.)
- 19.4.2.1. Overview
- 19.4.2.2. Treatment Portfolio
- 19.4.2.3. Sales Footprint
- 19.4.2.4. Key Financials
- 19.4.2.5. SWOT Analysis
- 19.4.2.6. Strategy Overview
- 19.4.3. Riemann A/S (Orkla)
- 19.4.3.1. Overview
- 19.4.3.2. Treatment Portfolio
- 19.4.3.3. Sales Footprint
- 19.4.3.4. Key Financials
- 19.4.3.5. SWOT Analysis
- 19.4.3.6. Strategy Overview
- 19.4.4. SweatBlock
- 19.4.4.1. Overview
- 19.4.4.2. Treatment Portfolio
- 19.4.4.3. Sales Footprint
- 19.4.4.4. Key Financials
- 19.4.4.5. SWOT Analysis
- 19.4.4.6. Strategy Overview
- 19.4.5. Certain Dri
- 19.4.5.1. Overview
- 19.4.5.2. Treatment Portfolio
- 19.4.5.3. Sales Footprint
- 19.4.5.4. Key Financials
- 19.4.5.5. SWOT Analysis
- 19.4.5.6. Strategy Overview
- 19.4.6. miraDry, Inc. (Sientra)
- 19.4.6.1. Overview
- 19.4.6.2. Treatment Portfolio
- 19.4.6.3. Sales Footprint
- 19.4.6.4. Key Financials
- 19.4.6.5. SWOT Analysis
- 19.4.6.6. Strategy Overview
- 19.4.7. STRATUS PHARMACEUTICALS INC
- 19.4.7.1. Overview
- 19.4.7.2. Treatment Portfolio
- 19.4.7.3. Sales Footprint
- 19.4.7.4. Key Financials
- 19.4.7.5. SWOT Analysis
- 19.4.7.6. Strategy Overview
- 19.4.8. Duradry
- 19.4.8.1. Overview
- 19.4.8.2. Treatment Portfolio
- 19.4.8.3. Sales Footprint
- 19.4.8.4. Key Financials
- 19.4.8.5. SWOT Analysis
- 19.4.8.6. Strategy Overview
- 19.4.9. Persōn & Covey
- 19.4.9.1. Overview
- 19.4.9.2. Treatment Portfolio
- 19.4.9.3. Sales Footprint
- 19.4.9.4. Key Financials
- 19.4.9.5. SWOT Analysis
- 19.4.9.6. Strategy Overview
- 19.4.10. GlaxoSmithKline Plc.
- 19.4.10.1. Overview
- 19.4.10.2. Treatment Portfolio
- 19.4.10.3. Sales Footprint
- 19.4.10.4. Key Financials
- 19.4.10.5. SWOT Analysis
- 19.4.10.6. Strategy Overview
- 19.4.11. Carpe
- 19.4.11.1. Overview
- 19.4.11.2. Treatment Portfolio
- 19.4.11.3. Sales Footprint
- 19.4.11.4. Key Financials
- 19.4.11.5. SWOT Analysis
- 19.4.11.6. Strategy Overview
- 19.4.12. SweatStop® International
- 19.4.12.1. Overview
- 19.4.12.2. Treatment Portfolio
- 19.4.12.3. Sales Footprint
- 19.4.12.4. Key Financials
- 19.4.12.5. SWOT Analysis
- 19.4.12.6. Strategy Overview
- 19.4.13. CORAD Healthcare
- 19.4.13.1. Overview
- 19.4.13.2. Treatment Portfolio
- 19.4.13.3. Sales Footprint
- 19.4.13.4. Key Financials
- 19.4.13.5. SWOT Analysis
- 19.4.13.6. Strategy Overview
- 19.4.14. ZeroSweat
- 19.4.14.1. Overview
- 19.4.14.2. Treatment Portfolio
- 19.4.14.3. Sales Footprint
- 19.4.14.4. Key Financials
- 19.4.14.5. SWOT Analysis
- 19.4.14.6. Strategy Overview
- 20. Assumptions and Acronyms Used
- 21. Research Methodology
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook